194 related articles for article (PubMed ID: 3274405)
1. Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients.
Magalini SC; Nanni G; Sambo A; Agnes S; Luciani G; Pozzetto A; Avolio A; Cittadini A; Castagneto M
Transplant Proc; 1987 Feb; 19(1 Pt 2):1686-8. PubMed ID: 3274405
[No Abstract] [Full Text] [Related]
2. Monitoring the response to anti-rejection therapy with serum neopterin.
Smillie AE; Rigby RJ; Petrie JJ
Transplant Proc; 1989 Feb; 21(1 Pt 2):1869-70. PubMed ID: 2652608
[No Abstract] [Full Text] [Related]
3. Fractional excretion of sodium is an early predictor of cyclosporine nephrotoxicity after renal transplantation.
Morales JM; Andrés A; Hernández E; Prieto C; Ortuño T; Montoyo C; Moreno F; Rodriguez-Paternina E; Farías J; Rodicio JL
Transplant Proc; 1990 Aug; 22(4):1728-9. PubMed ID: 2389444
[No Abstract] [Full Text] [Related]
4. Monitoring of serum beta 2 microglobulin and neopterin levels in renal transplant recipients: increased values during impaired renal function and cytomegalovirus infection.
Bäckman L; Ringdén O; Björkhem I
Transplant Proc; 1988 Jun; 20(3):410-2. PubMed ID: 2837852
[No Abstract] [Full Text] [Related]
5. Neopterin excretion for kidney transplant monitoring: relationship with antilymphocyte globulin treatment.
Noel C; Dhondt JL; Walter MP; Dracon M; Pruvot FR; Wattine O; Lelievre G; Dequiedt P
Transplant Proc; 1987 Feb; 19(1 Pt 2):1689-90. PubMed ID: 3274406
[No Abstract] [Full Text] [Related]
6. Combined measurements of urinary neopterin, beta 2-microglobulin and serum gamma-interferon for early detection of renal graft rejection following change from cyclosporin A to immunosuppressive combination therapy.
Lin CY; Shann TY; Lui WY; Peng FK
Transplant Proc; 1989 Feb; 21(1 Pt 2):1874-7. PubMed ID: 2540550
[No Abstract] [Full Text] [Related]
7. Pancreatic juice neopterin excretion--reliable marker for detection of pancreatic allograft rejection.
Königsrainer A; Reibnegger G; Ofner D; Klima G; Tauscher T; Margreiter R
Transplant Proc; 1990 Apr; 22(2):671-2. PubMed ID: 1691547
[No Abstract] [Full Text] [Related]
8. Monitoring of the serum neopterin/creatinine ratio in renal transplantation.
Hacini D; Guerin C; Berthoux P; Ville G; Berthoux F
Transplant Proc; 1987 Feb; 19(1 Pt 3):2185-6. PubMed ID: 3274488
[No Abstract] [Full Text] [Related]
9. Neopterin changes after clinical heart transplantation.
Wang SS; Chu SH; Ko WJ
Transplant Proc; 1996 Jun; 28(3):1730-2. PubMed ID: 8658860
[No Abstract] [Full Text] [Related]
10. Lack of predictivity of serum neopterin, soluble interleukin-2 receptor, and serum amyloid A in long-term kidney transplant recipients.
Magalini SC; Nanni G; Tacchino RM; Avolio AW; Castagneto M
Transplant Proc; 1992 Dec; 24(6):2547-8. PubMed ID: 1465861
[No Abstract] [Full Text] [Related]
11. Comparison of serum neopterin levels and urinary neopterin excretion in renal allograft recipients.
Aulitzky WE; Tilg H; Niederwieser D; Riccabona G; Obendorf L; Margreiter R; Pfaller W; Huber C
Clin Nephrol; 1988 May; 29(5):248-52. PubMed ID: 3293855
[TBL] [Abstract][Full Text] [Related]
12. Tubular markers in renal transplant patients under cyclosporine.
Martinez L; Vio C; Kychenthal A; Mendoza S; Quiroga T
Transplant Proc; 1990 Oct; 22(5):2277-9. PubMed ID: 2219366
[No Abstract] [Full Text] [Related]
13. Changes in urinary interleukin-2 in kidney transplant recipients.
Kumano K; Irie A; Mashimo S; Endo T; Koshiba K
Transplant Proc; 1996 Jun; 28(3):1248-9. PubMed ID: 8658644
[No Abstract] [Full Text] [Related]
14. Posttransplant neopterin excretion in renal allograft recipients--a reliable diagnostic aid for acute rejection and a predictive marker of long-term graft survival.
Reibnegger G; Aichberger C; Fuchs D; Hausen A; Spielberger M; Werner ER; Margreiter R; Wachtehr H
Transplantation; 1991 Jul; 52(1):58-63. PubMed ID: 1858155
[TBL] [Abstract][Full Text] [Related]
15. The differentiation of acute renal allograft rejection and cyclosporine nephrotoxicity by simple urine cytology.
Williamson EP; Millar RJ; Criddle RA; Sells RA
Transplant Proc; 1987 Feb; 19(1 Pt 2):1785-6. PubMed ID: 3274423
[No Abstract] [Full Text] [Related]
16. The neopterin/creatinine ratio cannot be used to diagnose rejection episodes in renal transplant recipients.
Bäckman L; Ringdén O
Nephron; 1989; 53(3):287. PubMed ID: 2797354
[No Abstract] [Full Text] [Related]
17. Increase in N-acetyl-beta-glucosaminidase excretion as a marker of kidney damage in cyclosporine-treated renal allografts.
Avolio AW; Nanni G; Citterio F; Pozzetto U; Magalini SC; Zappacosta B; Tacchino RM; Zuppi C; Castagneto M
Transplant Proc; 1987 Feb; 19(1 Pt 3):2086-7. PubMed ID: 3274475
[No Abstract] [Full Text] [Related]
18. Monitoring of heart allograft rejection by simultaneous measurement of serum beta 2-microglobulin and urinary neopterin.
Schmitt F; Myara I; Benoit MO; Guillemain R; Amrein C; Dreyfus G; Paris M; Moatti N
Ann Biol Clin (Paris); 1989; 47(5):237-41. PubMed ID: 2662838
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of combination of biologic markers (C-reactive protein, neopterin, and microalbuminuria) in the follow-up of kidney transplantation in children: four years of clinical experience.
Fischbach M; Desprez P; Mengus L; Christman D; Marcellin L; Chenard MP; Hamel G; Koehl C; Simeoni U; Boudjema K
Transplant Proc; 1994 Feb; 26(1):72-4. PubMed ID: 8109029
[No Abstract] [Full Text] [Related]
20. Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study.
Morales JM; Andrés A; Alvarez C; Prieto C; Ortuño B; Ortuño T; Paternina ER; Hernandez Poblete G; Praga M; Ruilope LM
Transplant Proc; 1990 Aug; 22(4):1733-5. PubMed ID: 2389446
[No Abstract] [Full Text] [Related]
[Next] [New Search]
